AcelRx Pharmaceuticals, Inc. at the Piper Jaffray Healthcare Conference (Replay)
11/29/16 at 12:00 p.m. ET
Analyst and Investor Meeting (Replay)
12/01/16 at 8:30 a.m. ET
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain.
ACRX (Common Stock) $2.90+0.15 (5.45%)
|Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources|
There are currently no events scheduled.
|Get help downloading or viewing the above file types|
Receive E-mail Alerts
|Sign up to receive e-mail alerts whenever AcelRx Pharmaceuticals, Inc. posts new information to the site. Just enter your e-mail address and click Submit.|